Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lysosome function and autophagy pathway is a set of interconnected mechanisms by which cells degrade and recycle intracellular components and macromolecules via lysosome-dependent processes. The primary forms—macroautophagy, microautophagy, and chaperone-mediated autophagy—all culminate in the lysosomal degradation of cellular material. This pathway maintains cellular homeostasis, responds to metabolic stress, removes damaged organelles and proteins, and is implicated in numerous diseases including neurodegeneration, cancer, and lysosomal storage disorders.
mTOR inhibition induces autophagy; Lysosomal pH modulation inhibits degradation; Fusion/fission inhibition affects vesicle flux.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosome function and autophagy pathway.